Login / Signup

Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis.

Carla De GiovanniPatrizia NanniLorena LanduzziMarianna L IanzanoGiordano NicolettiStefania CrociArianna PalladiniPier-Luigi Lollini
Published in: BMC cancer (2019)
Immune targeting of autocrine IGF2 inhibited rhabdomyosarcoma genesis and metastatic growth.
Keyphrases
  • cancer therapy
  • squamous cell carcinoma
  • small cell lung cancer
  • pi k akt
  • binding protein
  • growth hormone
  • drug delivery